Our oral corticosteroid use (dispensed) measure uses claims data to determine the percentage of patients in our population (Adult Asthma, Pediatric Asthma, and COPD) with 0, 1, or 2+ oral corticosteroid medication claims (total number of oral corticosteroid fills) in the measurement year. A lower proportion with 2+ OCS fills indicates better performance.
INHALE prepares regular PO and Clinical level newsletters that contain:
Support for the INHALE CQI is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs.
Although Blue Cross Blue Shield of Michigan and the INHALE CQI work in partnership, the opinions, beliefs, and viewpoints expressed by INHALE CQI do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.